이상반응 보고

VAERS ID	2594210
성별	여성
나이
주 코드	FR
제약회사	PFIZER\BIONTECH
로트 번호
예방접종 횟수
접종일
발병일
상태	사망

증상

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

thromboembolism; This is a spontaneous report received from non-contactable reporter(s) (Physician) from a sales representative.
A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation.
The patient's relevant medical history and concomitant medications were not reported.
The following information was reported: EMBOLISM (death, medically significant), outcome "fatal", described as "thromboembolism".
The patient date of death was unknown.
Reported cause of death: "Thromboembolism".
It was not reported if an autopsy was performed.
Clinical information: It was reported that, after the application of the Pfizer biontech vaccine in two patients close to the doctor, they suffered from complications of thromboembolism that caused death in both patients.
One of the patients was aging, and the other was a first daughter for whom reporter was not available for age.
No comorbidities identified at the time of the event.
It was unknown if the Autopsy was done.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.
; Sender's Comments: Based on the limited information available, the reported event Embolism is more likely an intercurrent or due to underlying medical condition, however the contributory role of the suspect product BNT162b2 cannot be excluded.
The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.
Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
; Reported Cause(s) of Death: Thromboembolism